Pan-cancer analysis of the extent and consequences of intratumor heterogeneity

[1]  Steven J. M. Jones,et al.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.

[2]  Z. Szallasi,et al.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.

[3]  Subhajyoti De,et al.  An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples , 2015, Briefings Bioinform..

[4]  Charles Swanton,et al.  Cancer evolution constrained by mutation order. , 2015, New England Journal of Medicine.

[5]  E. Mroz,et al.  Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas , 2015, PLoS medicine.

[6]  Matthew N Davies,et al.  Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale , 2015, Current opinion in genetics & development.

[7]  Benjamin J. Raphael,et al.  Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data , 2014, Bioinform..

[8]  P. Hufnagl,et al.  Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers , 2014, International journal of cancer.

[9]  Sohrab P. Shah,et al.  TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data , 2014, Genome research.

[10]  Bo Li,et al.  A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data , 2014, Genome Biology.

[11]  N. Navin,et al.  Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.

[12]  Adam A. Margolin,et al.  Assessing the clinical utility of cancer genomic and proteomic data across tumor types , 2014, Nature Biotechnology.

[13]  D. Burgess.  Evolution: Cancer drivers everywhere? , 2014, Nature Reviews Genetics.

[14]  Peter Donnelly,et al.  Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden , 2014, Nature Communications.

[15]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[16]  H. Ikeda,et al.  Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization. , 2014, Human pathology.

[17]  Esti Yeger-Lotem,et al.  Cancer Evolution Is Associated with Pervasive Positive Selection on Globally Expressed Genes , 2014, PLoS genetics.

[18]  Robin L. Jones,et al.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. , 2014, Cell reports.

[19]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[20]  Noemi Andor,et al.  EXPANDS: expanding ploidy and allele frequency on nested subpopulations , 2013, Bioinform..

[21]  Fatima Al-Shahrour,et al.  Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. , 2013, Nature chemical biology.

[22]  A. Jauch,et al.  Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[24]  Joshua F. McMichael,et al.  DGIdb - Mining the druggable genome , 2013, Nature Methods.

[25]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[26]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[27]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[28]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[29]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[30]  M. Vitale.  Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. , 2013, Thyroid : official journal of the American Thyroid Association.

[31]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[32]  Mahadev Satyanarayanan,et al.  OpenSlide: A vendor-neutral software foundation for digital pathology , 2013, Journal of pathology informatics.

[33]  A. McKenna,et al.  Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.

[34]  H. Iwase,et al.  Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens , 2013, Breast Cancer.

[35]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[36]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[37]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[38]  Sohrab P. Shah,et al.  JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data , 2012, Bioinform..

[39]  John Quackenbush,et al.  Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV , 2011, Bioinform..

[40]  Z. Szallasi,et al.  Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[41]  W. Cavenee,et al.  Heterogeneity maintenance in glioblastoma: a social network. , 2011, Cancer research.

[42]  Zoltan Szallasi,et al.  Paradoxical relationship between chromosomal instability and survival outcome in cancer. , 2011, Cancer research.

[43]  Xiaohong Li,et al.  A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma , 2010, Cancer Prevention Research.

[44]  Wei Wang,et al.  Detection and classification of thyroid follicular lesions based on nuclear structure from histopathology images , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[45]  J. Salk.  Clonal evolution in cancer , 2010 .

[46]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[47]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[48]  M. Tsao,et al.  Tissue Heterogeneity of EGFR Mutation in Lung Adenocarcinoma , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[49]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[50]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[51]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[52]  Manfred Eigen,et al.  The error threshold. , 2005, Virus research.

[53]  John Maynard Smith,et al.  The major evolutionary transitions , 1995, Nature.

[54]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.